Private Hospitals Carrying Out Illegal Gender Selection
By Saudi Gazette,
Saudi Gazette
| 12. 18. 2014
DAMMAM — Private hospitals are carrying out pre-conception gender selection operations and reporting them as IV fertilization or artificial fertilization in response to a growing number of patients’ requests, Al-Hayat daily reported.
Pre-conception gender selection operations are prohibited by the Ministry of Health although there are no religious prohibitions.
Sheikh Khalid Abdulah Al-Muslih said in his study on such procedures that scholars are split on the issue.
There is no religious text forbidding gender selection before conception, said Sheikh Al-Muslih.
Eastern Province Health Affairs spokesman Khalid Al-Osaimi said such operations are forbidden and would never happen in public hospitals. Sociologists believed parents who want such operations are looking to have boys, especially if there are none in their families.
Sociologist Saleh Al-Nimer said pre-conception gender selection operations have led to decreased rates of divorce in the Kingdom’s patriarchal society.
Many wives fear their husbands will replace them if they do not conceive a boy, said Al-Nimer.
The Eastern Province’s supervisor of private hospitals’ fertility units Dr. Essam Al-Hameed said these operations are not carried out in public hospitals, only private...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...